Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Eye Cancer, Retinoblastoma

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Eye Cancer, Retinoblastoma in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeda, M1
Haga, M1
Yamada, H1
Kinoshita, M1
Otsuka, M1
Tsuboi, S1
Moriyama, Y1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Eye Cancer, Retinoblastoma

ArticleYear
Ionotropic glutamate receptors expressed in human retinoblastoma Y79 cells.
    Neuroscience letters, 2000, Nov-17, Volume: 294, Issue:2

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Blot

2000